Marker Therapeutics Reports Non-Clinical Proof-of-Concept Data and Update on Clinical Readiness for the MT-401 Off-the-Shelf Program HOUSTON, Aug. 07, 2023 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for...

Industry’s Only Family of Standard Non-Hybrid Space-Grade Power Converters Now Includes 28 Volt (V)-Input Radiation-Tolerant Options CHANDLER, Ariz., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Space system designers cannot easily support non-standard voltages or add functions with traditional hybrid-style power converters. Microchip...